Evidence map›Paper›PMID 28163956›Full record

ArticleJournal of intercultural ethnopharmacology

Chinelo Ezeani, Ifeoma Ezenyi, Theophine Okoye, Charles Okoli

Open access · diamondAbstract read
In one paragraph

Article in Journal of intercultural ethnopharmacology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 59 citations in OpenAlex.

  1. Trial
  2. Therapeutic Potential of OzonatedPharmaceuticals (Basel, Switzerland) · 2025
    Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Ameliorative Effect ofMolecules (Basel, Switzerland) · 2022
    Article
  10. Article
  11. Review
  12. Review
  13. Hypoglycemic efficacy ofVeterinary world · 2020
    Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Chinelo EzeaniDepartment of Pharmacology & Toxicology, Faculty of Pharmaceutical Sciences, University of Nigeria, Nsukka 410001, Enugu State, Nigeria.
Ifeoma EzenyiDepartment of Pharmacology and Toxicology, NIPRD, Abuja, Nigeria.
Theophine OkoyeDepartment of Pharmacology & Toxicology, Faculty of Pharmaceutical Sciences, University of Nigeria, Nsukka 410001, Enugu State, Nigeria.
Charles OkoliDepartment of Pharmacology & Toxicology, Faculty of Pharmaceutical Sciences, University of Nigeria, Nsukka 410001, Enugu State, Nigeria.
University of Nigeria · NGNational Institute for Pharmaceutical Research and Development · NG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aim

methodsAntihyperglycemic effect of the extract was determined by its effects on α-amylase and α-glucosidase

resultsThe treatment with 100 and 200 mg/kg extract significantly (

conclusionsThe antidiabetic properties of the extract may be due to its ability to suppress endogenous glucose release, inhibit glycogenolysis and/or stimulate glycogenesis.

Indexed as

Antidiabeticdiabetes mellitushyperglycemiaOcimum basilicum

Identifiers

PMID28163956
PMCPMC5289084
OpenAlexW2569221398

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.